Financials of Alkem Laboratories Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Alkem Laboratories Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +2,9032,9683,4403,3242,9363,0323,4153,3743,1443,3714,0013,7373,603
Expenses +2,5492,5792,6932,6162,5342,4232,6622,6152,7522,6323,0802,9093,086
Operating Profit353389747708402609753759391739921828517
OPM %12%13%22%21%14%20%22%23%12%22%23%22%14%
Other Income +-346664276120134931461491049065
Interest29303025272928362830354254
Depreciation7872747083807985112889495106
Profit before tax212353648655367619780731396771896781423
Tax %68%18%5%8%17%11%10%12%18%13%13%16%40%
Net Profit +68288615604304550702641322668779653251
EPS in Rs5.9423.9851.9049.7624.5545.6057.6052.3425.5855.5663.9953.1919.78

Financials of Alkem Laboratories Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +3,6744,9055,6886,4017,3578,3448,86510,63411,59912,66812,96514,712
Expenses +3,2484,0384,6875,3926,2376,8686,9208,5809,97710,41910,45211,707
Operating Profit4278661,0011,0091,1201,4761,9452,0541,6222,2492,5123,005
OPM %12%18%18%16%15%18%22%19%14%18%19%20%
Other Income +17622711011582102230146101186494409
Interest8171455555655952107112122161
Depreciation7193101143193253275304310299357382
Profit before tax4519289659269551,2601,8421,8441,3052,0232,5272,871
Tax %13%19%6%31%19%9%12%9%23%10%12%18%
Net Profit +3927529056387741,1491,6181,6801,0071,8112,2152,351
EPS in Rs32.7562.0274.6152.7763.6194.26132.57137.6382.31150.19181.11192.51
Dividend Payout %12%20%20%25%25%27%23%25%61%27%25%28%

Financials of Alkem Laboratories Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital242424242424242424242424
Reserves2,9753,6684,4444,8405,4156,1377,3538,6149,02110,28811,96113,796
Borrowings +1,3066586599989441,6161,7072,6681,3971,4181,3812,047
Other Liabilities +9861,1841,4401,8031,8242,1692,4352,7633,3153,8444,3255,006
Total Liabilities5,2915,5346,5687,6648,2089,94611,51914,06913,75715,57517,69120,873
Fixed Assets +1,3741,4501,7972,2842,5302,9082,7932,9022,6832,8732,8524,015
CWIP111172299381493363393339323159548138
Investments4815095534443242613333716224841,8461,869
Other Assets +3,3253,4033,9184,5554,8616,4138,00010,45710,12912,06012,44514,851
Total Assets5,2915,5346,5687,6648,2089,94611,51914,06913,75715,57517,69120,873

Financials of Alkem Laboratories Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +3257264712667805851,2651,1111,6821,9481,913
Cash from Investing Activity +-235205-294-351-318-737-995-1,433120-1,011-1,288
Cash from Financing Activity +-52-927-13885-37979-272380-1,761-1,145-811
Net Cash Flow39340082-73-25842-207-186
Free Cash Flow190472-163-4112532371,1167831,4531,7611,278
CFO/OP101%107%73%47%92%59%86%73%121%105%96%

Financials of Alkem Laboratories Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days524246626272666567656974
Inventory Days169169198221186198241262194197224239
Days Payable10110812214711910411210287129141161
Cash Conversion Cycle121103122135129167196225174132152152
Working Capital Days-521334405544483166135124141
ROCE %12%23%21%17%16%18%22%18%14%20%20%21%